0001493152-23-006389.txt : 20230301
0001493152-23-006389.hdr.sgml : 20230301
20230301160517
ACCESSION NUMBER: 0001493152-23-006389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230227
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SNYDER DAVID S
CENTRAL INDEX KEY: 0001398625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 23693407
MAIL ADDRESS:
STREET 1: ONE SCIENCE COURT
CITY: MADISON
STATE: WI
ZIP: 53711
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
X0306
4
2023-02-27
0
0001835022
Coya Therapeutics, Inc.
COYA
0001398625
SNYDER DAVID S
5850 SAN FELIPE ST., SUITE 500
HOUSTON,
TX
77057
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
3.85
2023-02-27
4
A
0
115000
0
A
2033-02-27
Common Stock
115000
115000
D
Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.
/s/ David Snyder
2023-03-01